Heard I - Search Results

1

Prevalence of type-specific HPV infection in Uruguay.

Berois N, Heard I, Fort Z, Alonso R, Sica A, Moerzinger P, Rodriguez G, Sancho-Garnier H, Osinaga E, Favre M. Berois N, et al. Among authors: heard i. J Med Virol. 2014 Apr;86(4):647-52. doi: 10.1002/jmv.23870. Epub 2013 Dec 30. J Med Virol. 2014. PMID: 24375018

2

Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies.

Bernard E, Pons-Salort M, Favre M, Heard I, Delarocque-Astagneau E, Guillemot D, Thiébaut AC. Bernard E, et al. Among authors: heard i. BMC Infect Dis. 2013 Aug 13;13:373. doi: 10.1186/1471-2334-13-373. BMC Infect Dis. 2013. PMID: 23941096 Free PMC article.

3

Human papillomavirus types distribution in organised cervical cancer screening in France.

Heard I, Tondeur L, Arowas L, Falguières M, Demazoin MC, Favre M. Heard I, et al. PLoS One. 2013 Nov 14;8(11):e79372. doi: 10.1371/journal.pone.0079372. eCollection 2013. PLoS One. 2013. PMID: 24244490 Free PMC article.

4

[Investigation on HPV DNA detection and genotyping practices used in French laboratories in 2009].

Heard I, Favre M, Fihman V. Heard I, et al. Ann Biol Clin (Paris). 2011 May-Jun;69(3):303-9. doi: 10.1684/abc.2011.0577. Ann Biol Clin (Paris). 2011. PMID: 21659046 Free article. French.

5

Exploring individual HPV coinfections is essential to predict HPV-vaccination impact on genotype distribution: a model-based approach.

Pons-Salort M, Letort V, Favre M, Heard I, Dervaux B, Opatowski L, Guillemot D. Pons-Salort M, et al. Among authors: heard i. Vaccine. 2013 Feb 6;31(8):1238-45. doi: 10.1016/j.vaccine.2012.11.098. Epub 2012 Dec 13. Vaccine. 2013. PMID: 23246257

6

Resequencing microarray technology for genotyping human papillomavirus in cervical smears.

Berthet N, Falguières M, Filippone C, Bertolus C, Bole-Feysot C, Brisse S, Gessain A, Heard I, Favre M. Berthet N, et al. Among authors: heard i. PLoS One. 2014 Nov 10;9(11):e109301. doi: 10.1371/journal.pone.0109301. eCollection 2014. PLoS One. 2014. PMID: 25383888 Free PMC article.

7

VALGENT: A protocol for clinical validation of human papillomavirus assays.

Arbyn M, Depuydt C, Benoy I, Bogers J, Cuschieri K, Schmitt M, Pawlita M, Geraets D, Heard I, Gheit T, Tommasino M, Poljak M, Bonde J, Quint W. Arbyn M, et al. Among authors: heard i. J Clin Virol. 2016 Mar;76 Suppl 1:S14-S21. doi: 10.1016/j.jcv.2015.09.014. Epub 2015 Oct 8. J Clin Virol. 2016. PMID: 26522865 Review.

8

Characteristics of HPV infection over time in European women who are HIV-1 positive.

Heard I, Cubie HA, Mesher D, Sasieni P; MACH-1 Study Group. Heard I, et al. BJOG. 2013 Jan;120(1):41-9. doi: 10.1111/1471-0528.12015. Epub 2012 Nov 2. BJOG. 2013. PMID: 23121095

9

Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.

Heard I, Tondeur L, Arowas L, Demazoin M, Falguières M, Parent Du Chatelet I; pour le groupe CHlaHPV. Heard I, et al. J Infect Dis. 2017 Mar 1;215(5):757-763. doi: 10.1093/infdis/jiw639. J Infect Dis. 2017. PMID: 28011911

10

Human Papillomavirus infection and cervical lesions in HIV infected women on antiretroviral treatment in Thailand.

Delory T, Ngo-Giang-Huong N, Rangdaeng S, Chotivanich N, Limtrakul A, Putiyanun C, Suriyachai P, Matanasarawut W, Jarupanich T, Liampongsabuddhi P, Heard I, Jourdain G, Lallemant M, Le Coeur S; PapilloV study group. Delory T, et al. Among authors: heard i. J Infect. 2017 May;74(5):501-511. doi: 10.1016/j.jinf.2017.02.007. Epub 2017 Feb 28. J Infect. 2017. PMID: 28254419

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page